News

Global market forecasts project a dramatic shift from today's recreational-dominated market to a trillion-dollar pharmaceutical-centric future within ...
Pharmaceutical construction projects often involve numerous stakeholders ... By identifying potential issues in the design phase, companies can avoid costly errors and ensure smoother project ...
STOCKHOLM, SE / ACCESS Newswire / June 4, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
STOCKHOLM, SE / ACCESS Newswire / June 3, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...
Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...
The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...
Discover how Bayer and BlueRock are redefining biotech partnerships. From breakthrough Parkinson’s therapies to a unique “arm ...
Ireland's government and pharmaceutical sector have broadly welcomed the European Council's 'pharma package' agreement, but opposition remains in Dublin over potential delays to affordable drugs.
The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...
As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...
Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal ...